Johnson & Johnson (JNJ) has finally broken out on the upside. Prices are retesting the highs established back in 2017 and 2018. Let's check out our favorite set of charts and indicators to see how this pharma powerhouse can climb in the first quarter of 2020.
More from Investing
The trend may not be very friendly right now but it is warning us that the chances of more downside are very high.
I'll want to pay close attention to Monday's price action in the TLT.
Our latest analysis and strategy on the graphics processing chip manufacturer.
Psychology indicators remain bullish.
All three are names that can survive if the shelter-in-place order in various areas in the United States extends post-Easter, and they'll benefit beyond COVID-19.